These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10529156)

  • 41. [Escherichia coli alpha-hemolysin antibodies in urinary tract infection].
    Galiński J; Nowicki B; Hebanowski M; Manitius A
    Pol Tyg Lek; 1981 Jul; 36(28):1051-3. PubMed ID: 7031622
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?
    Sundén F; Håkansson L; Ljunggren E; Wullt B
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S26-9. PubMed ID: 16843646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of urinary tract infections in patients with risk factors].
    Núñez Sánchez JC; Catalá Barceló MT; Navarro Obrer I; Balaguer Martínez JV
    Med Clin (Barc); 1999 Sep; 113(8):319. PubMed ID: 10603588
    [No Abstract]   [Full Text] [Related]  

  • 44. Recurrent urinary tract infections--uropathogen incidence and drug sensitivity.
    Zajaczkowska M; Zinkiewicz Z; Bieniaś B; Piechuta L; Szajner-Milart I; Majewski M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):275-83. PubMed ID: 16146092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recurrent diffuse peritonitis in chronic urinary tract infection. Case report].
    Schröder R; Ricklin T
    Schweiz Med Wochenschr; 1980 Mar; 110(11):414-5. PubMed ID: 6988958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bilateral endogenous Escherichia coli endophthalmitis.
    Zakka K; Hirose T
    Ann Ophthalmol; 1985 Mar; 17(3):212-3, 215. PubMed ID: 3922274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenetic aspects of chlamydia-associated urogenic arthritis: feasibility of microorganism reproduction in cells of articular cartilage].
    Panasiuk AF; Soldatova SI; Shubin SV; Kolkova NI; Martynova V
    Ter Arkh; 1998; 70(5):45-8. PubMed ID: 9644742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
    Killgore KM; March KL; Guglielmo BJ
    Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Barlam T; Moellering R
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11858221
    [No Abstract]   [Full Text] [Related]  

  • 50. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Urinary tract infections and pregnancy].
    Baleiras C; Campos A; Lourenço I; Revez AI
    Acta Med Port; 1998 Oct; 11(10):839-46. PubMed ID: 10021778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection.
    Otto G; Magnusson M; Svensson M; Braconier J; Svanborg C
    Clin Infect Dis; 2001 Jun; 32(11):1523-31. PubMed ID: 11340521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.
    Ha US; Cho YH
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroleptic malignant syndrome and Escherichia coli urosepsis.
    Teglia MQ; Hopkins TT; Cunha BA
    Heart Lung; 1991 Mar; 20(2):202-5. PubMed ID: 2004933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary tract infection in a healthy 10-year-old boy: an occult etiology.
    Bhatia SR; Hickey RW
    Pediatr Emerg Care; 2009 Sep; 25(9):590-1. PubMed ID: 19755897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escherichia coli Urinary Infection as a Cause of Acute Hemorrhagic Edema in Infancy.
    Breda L; Franchini S; Marzetti V; Chiarelli F
    Pediatr Dermatol; 2015; 32(6):e309-11. PubMed ID: 26447145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress in the treatment of chronic urinary tract infection--malacoplakia: current concepts.
    Scardino PL; Tilson PJ
    J Med Assoc Ga; 1983 Aug; 72(8):557-60. PubMed ID: 6355350
    [No Abstract]   [Full Text] [Related]  

  • 58. Urinary tract infections in surgical cases.
    Agarwal SL; Malhotra VK
    J Indian Med Assoc; 1972 Feb; 58(3):89-90. PubMed ID: 4112067
    [No Abstract]   [Full Text] [Related]  

  • 59. Escherichia coli primary aortitis presenting as sequelae of incompletely treated urinary tract infection.
    Johnstone JK; Garcia-Toca M; Slaiby JM; Marcaccio EJ; Chong TT
    J Vasc Surg; 2012 Jun; 55(6):1779-81. PubMed ID: 22386143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppressive therapy with norfloxacin in patients with recurrent and/or complicated urinary tract infection.
    Falck L; Bucht H; Stegmayr B; Svärd R
    Scand J Urol Nephrol Suppl; 1988; 110():307-11. PubMed ID: 3055255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.